Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
A. G. Renwick. (1993) Data‐derived safety factors for the evaluation of food additives and environmental contaminants. Food Additives & Contaminants 10:3, pages 275-305.
Read now
Read now
Sergey V. Geodakyan. (1993) Methodological Approach in the Study of Anticancer Drug Metabolism: Qualitative Considerations. Drug Metabolism Reviews 25:1-2, pages 153-172.
Read now
Read now
Peter Dogterom, Gerhard Zbinden & Gerd K. Reznik. (1992) Cardiotoxicity of Vasodilators and Positive Inotropic/Vasodilating Drugs in Dogs: An Overview. Critical Reviews in Toxicology 22:3-4, pages 203-241.
Read now
Read now
A. G. Renwick. (1991) Safety factors and establishment of acceptable daily intakes. Food Additives & Contaminants 8:2, pages 135-149.
Read now
Read now
Articles from other publishers (34)
Zhao-Yan Wen, Song Gao, Ting-Ting Gong, Yu-Ting Jiang, Jia-Yu Zhang, Yu-Hong Zhao & Qi-Jun Wu. (2021) Post-Diagnostic Beta Blocker Use and Prognosis of Ovarian Cancer: A Systematic Review and Meta-Analysis of 11 Cohort Studies With 20,274 Patients. Frontiers in Oncology 11.
Crossref
Crossref
Ting-Ting Gong, Qi-Jun Wu, Bei Lin, Shi-Kai Ruan, Miki Kushima & Masafumi Takimoto. (2019) Observational Studies on the Association Between Post-diagnostic Metformin Use and Survival in Ovarian Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology 9.
Crossref
Crossref
Xia Li & Jing Zhou. (2018) Impact of postdiagnostic statin use on ovarian cancer mortality: A systematic review and meta-analysis of observational studies. British Journal of Clinical Pharmacology 84:6, pages 1109-1120.
Crossref
Crossref
Flory T. Muanda, Odile Sheehy & Anick Bérard. (2017) Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study. British Journal of Clinical Pharmacology 83:11, pages 2557-2571.
Crossref
Crossref
. 2014. Handbook of Solvents. Handbook of Solvents
263
330
.
Niels Christian Ganderup, Warren Harvey, Jens Thing Mortensen & Wafa Harrouk. (2012) The Minipig as Nonrodent Species in Toxicology—Where Are We Now?. International Journal of Toxicology 31:6, pages 507-528.
Crossref
Crossref
Peter McAnulty, Anthony Dayan, Niels-Christian Ganderup & Kenneth HastingsJames Turk & M Laughlin. 2011. The Minipig in Biomedical Research. The Minipig in Biomedical Research
469
478
.
D. J. Snodin & A. Suitters. 2011. Stephens' Detection and Evaluation of Adverse Drug Reactions. Stephens' Detection and Evaluation of Adverse Drug Reactions
157
214
.
Beom Soo Shin, Jürgen B. Bulitta, Joseph P. Balthasar, Minki Kim, Yohan Choi & Sun Dong Yoo. (2010) Prediction of human pharmacokinetics and tissue distribution of apicidin, a potent histone deacetylase inhibitor, by physiologically based pharmacokinetic modeling. Cancer Chemotherapy and Pharmacology 68:2, pages 465-475.
Crossref
Crossref
S. Giraud, F. Favreau, N. Chatauret, R. Thuillier, S. Maiga & T. Hauet. (2011) Contribution of Large Pig for Renal Ischemia-Reperfusion and Transplantation Studies: The Preclinical Model. Journal of Biomedicine and Biotechnology 2011, pages 1-14.
Crossref
Crossref
SANFORD P. MARKEY. 2007. Principles of Clinical Pharmacology. Principles of Clinical Pharmacology
143
162
.
H. Manzano, A. Benedito de Sousa, B. Soto-Blanco, J. L. Guerra, P. C. Maiorka & S. L. Górniak. (2006) Effects of Long-term Cyanide Ingestion by Pigs. Veterinary Research Communications 31:1, pages 93-104.
Crossref
Crossref
T.G. Vermeire, A.J. Baars, J.G.M. Bessems, B.J. Blaauboer, W. Slob & J.J.A. Muller. 2007. Risk Assessment of Chemicals. Risk Assessment of Chemicals
227
280
.
Christopher Banks. 2006. Toxicological Testing Handbook. Toxicological Testing Handbook
149
184
.
Helen Tryphonas & Douglas Arnold. 2005. Investigative Immunotoxicology. Investigative Immunotoxicology
211
227
.
John H. Ansede & Dhiren R. Thakker. (2004) High‐throughput screening for stability and inhibitory activity of compounds toward cytochrome P450‐mediated metabolism. Journal of Pharmaceutical Sciences 93:2, pages 239-255.
Crossref
Crossref
Thierry Lavé, Olivier Luttringer, Patrick Poulin & Neil Parrott. 2004. Applications of Pharmacokinetic Principles in Drug Development. Applications of Pharmacokinetic Principles in Drug Development
133
175
.
B.J Blaauboer. (2003) The integration of data on physico-chemical properties, in vitro-derived toxicity data and physiologically based kinetic and dynamic as modelling a tool in hazard and risk assessment. A commentary. Toxicology Letters 138:1-2, pages 161-171.
Crossref
Crossref
Ivan Nestorov. (2003) Whole Body Pharmacokinetic Models. Clinical Pharmacokinetics 42:10, pages 883-908.
Crossref
Crossref
James L. Botsford. (2019) A Comparison of Ecotoxicological Tests. Alternatives to Laboratory Animals 30:5, pages 539-550.
Crossref
Crossref
K. D. Rainsford, H. Omar, A. Ashraf, A. T. Hewson, R. A. D. Bunning, R. Rishiraj, P. Shepherd & R. W. Seabrook. (2002) Recent pharmacodynamic and pharmacokinetic findings on oxaprozin. InflammoPharmacology 10:3, pages 185-239.
Crossref
Crossref
Bas J Blaauboer. (2002) The applicability of in vitro-derived data in hazard identification and characterisation of chemicals. Environmental Toxicology and Pharmacology 11:3-4, pages 213-225.
Crossref
Crossref
Bas J. Blaauboer, Joost DeJongh, Anna Forsby, J. Brian Houston, André Guillouzo, Martin D. Barratt, Marie Beckman & Robert D. Combes. 2002. The Practical Applicability of Toxicokinetic Models in the Risk Assessment of Chemicals. The Practical Applicability of Toxicokinetic Models in the Risk Assessment of Chemicals
155
194
.
Albert Li. 2001. Handbook of Drug Screening. Handbook of Drug Screening.
Bas J Blaauboer. (2001) Toxicodynamic modelling and the interpretation of in vitro toxicity data. Toxicology Letters 120:1-3, pages 111-123.
Crossref
Crossref
Albert P Li, Chuang Lu, Julie A Brent, Chuong Pham, Andrew Fackett, Charles E Ruegg & Paul M Silber. (1999) Cryopreserved human hepatocytes: characterization of drug-metabolizing activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug–drug interaction potential. Chemico-Biological Interactions 121:1, pages 17-35.
Crossref
Crossref
P. Olinga, D.K.F. Meijer, M.J.H. Slooff & G.M.M. Groothuis. (1997) Liver slices in in vitro pharmacotoxicology with special reference to the use of human liver tissue. Toxicology in Vitro 12:1, pages 77-100.
Crossref
Crossref
A. Mukherjee, V. G. Hale, O. Borga & R. Stein. (1996) Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats. Inflammation Research 45:11, pages 531-540.
Crossref
Crossref
M. Potier, B. Lakhdar, D. Merlet & J. Cambar. (1995) Interest and limits of human tissue and cell use in pharmacotoxicology. Cell Biology and Toxicology 11:3-4, pages 133-139.
Crossref
Crossref
Mabel C. Calleja, Guido Persoone & Paul Geladi. (2020) The Predictive Potential of a Battery of Ecotoxicological Tests for Human Acute Toxicity, as Evaluated with the First 50 MEIC Chemicals. Alternatives to Laboratory Animals 21:3, pages 330-349.
Crossref
Crossref
Bas J. Blaauboer, Heleen M. Wortelboer & Wim C. Mennes. (2020)
The Use of Liver Cell Cultures Derived from Different Mammalian Species in
In Vitro
Toxicological Studies: Implementation in Extrapolation Models?
. Alternatives to Laboratory Animals 18:1_part_1, pages 251-258.
Crossref
Crossref
P. Tautu. 1989. Biologically Based Methods for Cancer Risk Assessment. Biologically Based Methods for Cancer Risk Assessment
79
109
.
Wayne A. Colburn. (1988) Physiologic Pharmacokinetic Modeling. The Journal of Clinical Pharmacology 28:8, pages 673-677.
Crossref
Crossref
D. W. R. Bleyl. (1988) Review article Is the variational scope of individual sensitivity given enough consideration in evaluation of risks caused by toxicological substances in food?. Food / Nahrung 32:9, pages 831-838.
Crossref
Crossref